{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:52:29Z","timestamp":1789653149032,"version":"4.0.0"},"reference-count":145,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/hrp.0000000000000068","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T12:05:24Z","timestamp":1441109124000},"page":"354-367","source":"Crossref","is-referenced-by-count":40,"title":["Psychosis in Later Life"],"prefix":"10.1097","volume":"23","author":[{"given":"Mark A.","family":"Colijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley H.","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Grossberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.psc.2011.02.008","article-title":"New wine in old bottle: late-life psychosis.","volume":"34","author":"Iglewicz","year":"2011","journal-title":"Psychiatr Clin North Am"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","article-title":"Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group.","volume":"157","author":"Howard","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R5-6-20210129","first-page":"414","article-title":"Is late-onset schizophrenia a subtype of schizophrenia Acta Psychiatr S","volume":"122","author":"Vahia","year":"2010","journal-title":"cand"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1017\/S1041610212001731","article-title":"Dimensions of positive symptoms in late versus early onset psychosis.","volume":"25","author":"Mason","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population.","volume":"64","author":"Perala","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.archger.2010.02.007","article-title":"Clinical correlates of age of onset in psychotic depression.","volume":"52","author":"Gournellis","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","article-title":"Epidemiology of and risk factors for psychosis of Alzheimers disease: a review of 55 studies published from 1990 to 2003.","volume":"162","author":"Ropacki","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019442-200002000-00004","article-title":"Psychosis of Alzheimers disease and related dementias. Diagnostic criteria for a distinct syndrome.","volume":"8","author":"Jeste","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/awq001","article-title":"Assessment and familial aggregation of psychosis in Alzheimers disease from the National Institute on Aging Late Onset Alzheimers Disease Family Study.","volume":"133","author":"Sweet","year":"2010","journal-title":"Brain"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mds.22839","article-title":"The changing face of Parkinsons disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.","volume":"25","author":"Fenelon","year":"2010","journal-title":"Mov Disord"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/mds.23891","article-title":"Visual symptoms in Parkinsons disease and Parkinsons disease dementia.","volume":"26","author":"Archibald","year":"2011","journal-title":"Mov Disord"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1155\/2013\/645429","article-title":"Parkinson disease psychosis: update.","volume":"27","author":"Friedman","year":"2013","journal-title":"Behav Neurol"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/JGP.0b013e3180cc1fdf","article-title":"Classification of psychotic symptoms in dementia with Lewy bodies.","volume":"15","author":"Nagahama","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.parkreldis.2012.10.013","article-title":"Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimers disease.","volume":"19","author":"Ferman","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/ps.50.9.1178","article-title":"Older patients with schizophrenia: challenges in the coming decades.","volume":"50","author":"Palmer","year":"1999","journal-title":"Psychiatr Serv"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10673220127883","article-title":"Schizophrenia in late life: findings challenge traditional concepts.","volume":"9","author":"Palmer","year":"2001","journal-title":"Harv Rev Psychiatry"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/JGP.0b013e3182011b7f","article-title":"Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a Dutch catchment area.","volume":"20","author":"Meesters","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1176\/ajp.152.5.722","article-title":"Clinical and neuropsychological characteristics of patients with late-onset schizophrenia.","volume":"152","author":"Jeste","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R24-6-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/psyg.12032","article-title":"Clinical features of late-onset schizophrenia in japan: comparison with early-onset cases.","volume":"13","author":"Yasuda","year":"2013","journal-title":"Psychogeriatrics"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/1516-4446-2013-1205","article-title":"Delusional disorder: no gender differences in age at onset, suicidal ideation, or suicidal behavior.","volume":"36","author":"Gonzalez-Rodriguez","year":"2014","journal-title":"Rev Bras Psiquiatr"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/schbul\/sbt075","article-title":"Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).","volume":"39","author":"Owoeye","year":"2013","journal-title":"Schizophr Bull"},{"key":"R27-6-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0749-0690(18)30481-6","article-title":"Geriatric delusional depression.","volume":"8","author":"Meyers","year":"1992","journal-title":"Clin Geriatr Med"},{"key":"R28-6-20210129","first-page":"236","article-title":"Delusional depression in the elderly: a community study.","volume":"22","author":"Kivela","year":"1989","journal-title":"Z Gerontol"},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopsych.2005.02.004","article-title":"Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients.","volume":"58","author":"Jeste","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jagp.2013.01.051","article-title":"Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality.","volume":"21","author":"Vilalta-Franch","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/gps.3820","article-title":"Behavioral symptoms in mild cognitive impairment as compared with Alzheimers disease and healthy older adults.","volume":"28","author":"Van der Mussele","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jagp.2013.01.041","article-title":"Neuropsychiatric symptom clusters of Alzheimer disease in Hong Kong Chinese: correlates with caregiver burden and depression.","volume":"21","author":"Cheng","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"R33-6-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0891988710373596","article-title":"Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia.","volume":"24","author":"Ostling","year":"2011","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R34-6-20210129","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/WAD.0b013e31820d89b6","article-title":"Neuropsychiatric profiles in dementia.","volume":"25","author":"Johnson","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R36-6-20210129","first-page":"675630","article-title":"New thoughts on thought disorders in Parkinsons disease: review of current research strategies and challenges.","volume":"2011","author":"Goldman","year":"2011","journal-title":"Parkinsons Dis"},{"key":"R37-6-20210129","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson disease.","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch Neurol"},{"key":"R38-6-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinsons disease.","volume":"289","author":"Fenelon","year":"2010","journal-title":"J Neurol Sci"},{"key":"R39-6-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies.","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol Med"},{"key":"R40-6-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1155\/2013\/703924","article-title":"Visual hallucinations in PD and Lewy body dementias: old and new hypotheses.","volume":"27","author":"Onofrj","year":"2013","journal-title":"Behav Neurol"},{"key":"R41-6-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/medicina48010001","article-title":"Dementia with Lewy bodies: the principles of diagnostics, treatment, and management.","volume":"48","author":"Macijauskiene","year":"2012","journal-title":"Medicina (Kaunas)"},{"key":"R42-6-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.20001","article-title":"Secondary psychoses: an update.","volume":"12","author":"Keshavan","year":"2013","journal-title":"World Psychiatry"},{"key":"R43-6-20210129","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","article-title":"Delirium in elderly people.","volume":"383","author":"Inouye","year":"2014","journal-title":"Lancet"},{"key":"R44-6-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/pcn.12066","article-title":"Atypical antipsychotics in the treatment of delirium.","volume":"67","author":"Wang","year":"2013","journal-title":"Psychiatry Clin Neurosci"},{"key":"R45-6-20210129","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biopsych.2013.08.020","article-title":"Psychosis in Alzheimers disease.","volume":"75","author":"Murray","year":"2014","journal-title":"Biol Psychiatry"},{"key":"R46-6-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pscychresns.2012.01.008","article-title":"Neuroimaging of delusions in Alzheimers disease.","volume":"202","author":"Ismail","year":"2012","journal-title":"Psychiatry Res"},{"key":"R47-6-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1176\/jnp.15.3.346","article-title":"Psychiatric symptoms vary with the severity of dementia in probable Alzheimers disease.","volume":"15","author":"Lopez","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R48-6-20210129","first-page":"268","article-title":"Neuroanatomical correlates of clinical misidentification and misperception in senile dementia of the Alzheimer type.","volume":"52","author":"Forstl","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"R49-6-20210129","first-page":"1451","article-title":"HMPAO SPECT imaging of Alzheimers disease patients with similar content-specific autobiographic delusion: comparison using statistical parametric mapping.","volume":"41","author":"Staff","year":"2000","journal-title":"J Nucl Med"},{"key":"R50-6-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000089215","article-title":"Relationship between delusions and regional cerebral blood flow in Alzheimers disease.","volume":"21","author":"Nakano","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R51-6-20210129","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.neurobiolaging.2007.02.024","article-title":"Psychosis of Alzheimers disease: gender differences in regional perfusion.","volume":"29","author":"Moran","year":"2008","journal-title":"Neurobiol Aging"},{"key":"R52-6-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000284869","article-title":"Delusional misidentification in Alzheimers disease: a summary of clinical and biological aspects.","volume":"27","author":"Forstl","year":"1994","journal-title":"Psychopathology"},{"key":"R53-6-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/jnp.2006.18.2.191","article-title":"White matter changes associated with psychotic symptoms in Alzheimers disease patients.","volume":"18","author":"Lee","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R54-6-20210129","first-page":"627","article-title":"Are the behavioral symptoms of Alzheimers disease directly associated with neurodegeneration J Alzheimers D","volume":"21","author":"Serra","year":"2010","journal-title":"is"},{"key":"R55-6-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1017\/S1041610211000974","article-title":"Frontotemporal atrophy associated with paranoid delusions in women with Alzheimers disease.","volume":"24","author":"Whitehead","year":"2012","journal-title":"Int Psychogeriatr"},{"key":"R56-6-20210129","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/brain\/awn151","article-title":"Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimers disease.","volume":"131","author":"Bruen","year":"2008","journal-title":"Brain"},{"key":"R57-6-20210129","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.44.11.2055","article-title":"A SPECT study of delusions in Alzheimers disease.","volume":"44","author":"Starkstein","year":"1994","journal-title":"Neurology"},{"key":"R58-6-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0010-9452(08)70818-9","article-title":"Delusions in Alzheimers disease: SPET evidence of right hemispheric dysfunction.","volume":"35","author":"Staff","year":"1999","journal-title":"Cortex"},{"key":"R59-6-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/WNN.0b013e3181a7226c","article-title":"Confabulations on episodic and semantic memory questions are associated with different neurologic backgrounds in Alzheimer disease.","volume":"22","author":"Lee","year":"2009","journal-title":"Cogn Behav Neurol"},{"key":"R60-6-20210129","first-page":"264","article-title":"Psychometric and SPECT studies in Alzheimers disease with and without delusions.","volume":"8","author":"Ponton","year":"1995","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R61-6-20210129","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"R62-6-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000295115","article-title":"Insular hypoperfusion correlates with the severity of delusions in individuals with Alzheimers disease.","volume":"29","author":"Matsuoka","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R63-6-20210129","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1176\/ajp.152.10.1470","article-title":"SPECT findings on psychosis in Alzheimers disease.","volume":"152","author":"Kotrla","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R64-6-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/jnp.13.1.50","article-title":"The psychotic phenomenon in probable Alzheimers disease: a positron emission tomography study.","volume":"13","author":"Lopez","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R65-6-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1176\/jnp.10.4.433","article-title":"Alteration of regional cerebral glucose utilization with delusions in Alzheimers disease.","volume":"10","author":"Hirono","year":"1998","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R66-6-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1176\/appi.ajp.160.2.341","article-title":"Delusional thoughts and regional frontaltemporal cortex metabolism in Alzheimers disease.","volume":"160","author":"Sultzer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R67-6-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2007.04.017","article-title":"A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimers disease.","volume":"260","author":"Shinno","year":"2007","journal-title":"J Neurol Sci"},{"key":"R68-6-20210129","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/01.wnl.0000341932.21961.f3","article-title":"Increased striatal dopamine (D2D3) receptor availability and delusions in Alzheimer disease.","volume":"72","author":"Reeves","year":"2009","journal-title":"Neurology"},{"key":"R69-6-20210129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0891988713516544","article-title":"Neuroimaging findings in late-onset schizophrenia and bipolar disorder.","volume":"27","author":"Hahn","year":"2014","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R70-6-20210129","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1192\/bjp.165.4.474","article-title":"Quantitative magnetic resonance imaging volumetry distinguishes delusional disorder from late-onset schizophrenia.","volume":"165","author":"Howard","year":"1994","journal-title":"Br J Psychiatry"},{"key":"R71-6-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/ajp.152.3.447","article-title":"Quantitative magnetic resonance imaging of the brain in late-life schizophrenia.","volume":"152","author":"Corey-Bloom","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R72-6-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1440-1819.2000.00644.x","article-title":"Hippocampus and amygdala volumes in elderly schizophrenic patients as assessed by magnetic resonance imaging.","volume":"54","author":"Sachdev","year":"2000","journal-title":"Psychiatry Clin Neurosci"},{"key":"R73-6-20210129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00005053-200211000-00002","article-title":"Very late-onset schizophrenia-like psychosis: clinical and imaging characteristics in comparison with elderly patients with schizophrenia.","volume":"190","author":"Barak","year":"2002","journal-title":"J Nerv Ment Dis"},{"key":"R74-6-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1017\/S0033291799008685","article-title":"Mid-sagittal anatomy in late-onset schizophrenia.","volume":"29","author":"Sachdev","year":"1999","journal-title":"Psychol Med"},{"key":"R75-6-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1176\/jnp.9.2.251","article-title":"Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses.","volume":"9","author":"Symonds","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R76-6-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-9964(97)00088-1","article-title":"Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99MTC-HMPAO.","volume":"27","author":"Sachdev","year":"1997","journal-title":"Schizophr Res"},{"key":"R77-6-20210129","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/schbul\/19.4.783","article-title":"Quantitative D2 dopamine receptor PET and structural MRI changes in late-onset schizophrenia.","volume":"19","author":"Pearlson","year":"1993","journal-title":"Schizophr Bull"},{"key":"R78-6-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1399-5618.2008.00621.x","article-title":"Increased rates of white matter hyperintensities in late-onset bipolar disorder.","volume":"10","author":"Tamashiro","year":"2008","journal-title":"Bipolar Disord"},{"key":"R79-6-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pscychresns.2010.11.010","article-title":"Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implications.","volume":"192","author":"Vardi","year":"2011","journal-title":"Psychiatry Res"},{"key":"R80-6-20210129","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.neurobiolaging.2013.04.023","article-title":"Specific risk factors for microbleeds and white matter hyperintensities in Alzheimers disease.","volume":"34","author":"Benedictus","year":"2013","journal-title":"Neurobiol Aging"},{"key":"R81-6-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2010.07.015","article-title":"Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent.","volume":"33","author":"Jacobs","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R82-6-20210129","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.STR.27.8.1274","article-title":"Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.","volume":"27","author":"Longstreth","year":"1996","journal-title":"Stroke"},{"key":"R83-6-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-3223(90)90582-M","article-title":"Cerebral white matter disease in late-onset paranoid psychosis.","volume":"28","author":"Breitner","year":"1990","journal-title":"Biol Psychiatry"},{"key":"R84-6-20210129","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1176\/ajp.156.12.1958","article-title":"Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia.","volume":"156","author":"Sachdev","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R85-6-20210129","first-page":"230","article-title":"Late-onset paranoid psychosis as a distinct clinicopathologic entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset.","volume":"12","author":"Tonkonogy","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R86-6-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1192\/bjp.175.5.416","article-title":"Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation.","volume":"175","author":"Sachdev","year":"1999","journal-title":"Br J Psychiatry"},{"key":"R87-6-20210129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1099-1166(200012)15:12<1085::AID-GPS250>3.0.CO;2-X","article-title":"White matter hyperintensity volume in late-onset and early-onset schizophrenia.","volume":"15","author":"Rivkin","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"R88-6-20210129","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00019442-200512000-00009","article-title":"A diffusion tensor magnetic resonance imaging study of frontal cortex connections in very-late-onset schizophrenia-like psychosis.","volume":"13","author":"Jones","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"R89-6-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pscychresns.2012.05.009","article-title":"White matter microstructural abnormalities in patients with late-onset schizophrenia identified by a voxel-based diffusion tensor imaging.","volume":"212","author":"Chen","year":"2013","journal-title":"Psychiatry Res"},{"key":"R90-6-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/YCO.0b013e32835d9e6a","article-title":"Review of functional and anatomical brain connectivity findings in schizophrenia.","volume":"26","author":"Fitzsimmons","year":"2013","journal-title":"Curr Opin Psychiatry"},{"key":"R91-6-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11920-011-0189-z","article-title":"A tipping point in drug dosing in late-life schizophrenia.","volume":"13","author":"Tsuboi","year":"2011","journal-title":"Curr Psychiatry Rep"},{"key":"R92-6-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11920-996-0050-y","article-title":"Antipsychotic treatment for late-life schizophrenia.","volume":"4","author":"Sable","year":"2002","journal-title":"Curr Psychiatry Rep"},{"key":"R93-6-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2165\/11595830-000000000-00000","article-title":"Management of schizophrenia in late life with antipsychotic medications: a qualitative review.","volume":"28","author":"Suzuki","year":"2011","journal-title":"Drugs Aging"},{"key":"R94-6-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/JGP.0b013e31815a3e7a","article-title":"Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.","volume":"16","author":"Tzimos","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"R95-6-20210129","first-page":"CD004162","article-title":"Antipsychotic drug treatment for elderly people with late-onset schizophrenia.","volume":"2","author":"Essali","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R96-6-20210129","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JCP.0b013e3182905796","article-title":"Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature.","volume":"33","author":"Mews","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"R97-6-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/YIC.0000000000000020","article-title":"Effectiveness of long-acting injectable antipsychotics in delusional disorders with nonprominent hallucinations and without hallucinations.","volume":"29","author":"Gonzalez-Rodriguez","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"R98-6-20210129","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11920-012-0315-6","article-title":"Psychotic depressionbeyond the antidepressantantipsychotic combination.","volume":"14","author":"Nelson","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"R99-6-20210129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4088\/JCP.11r07324","article-title":"Are antipsychotics or antidepressants needed for psychotic depression A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.","volume":"73","author":"Farahani","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"R100-6-20210129","first-page":"214","article-title":"The treatment of psychotic depression: is there consensus among guidelines and psychiatrists J Affect D","volume":"145","author":"Leadholm","year":"2013","journal-title":"isord"},{"key":"R101-6-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/11587630-000000000-00000","article-title":"Schizoaffective disorder: a review of current research themes and pharmacological management.","volume":"25","author":"Kantrowitz","year":"2011","journal-title":"CNS Drugs"},{"key":"R102-6-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/11207440-000000000-00000","article-title":"Oral paliperidone: a review of its use in the management of schizoaffective disorder.","volume":"25","author":"Yang","year":"2011","journal-title":"CNS Drugs"},{"key":"R103-6-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/NDT.S12612","article-title":"Role of paliperidone extended-release in treatment of schizoaffective disorder.","volume":"6","author":"Canuso","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R104-6-20210129","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4088\/JCP.v69n0602","article-title":"Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.","volume":"69","author":"Salzman","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R106-6-20210129","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimers disease.","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med"},{"key":"R107-6-20210129","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.2008.07111779","article-title":"Clinical symptom responses to atypical antipsychotic medications in Alzheimers disease: phase 1 outcomes from the CATIE-AD effectiveness trial.","volume":"165","author":"Sultzer","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R108-6-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1114058","article-title":"Relapse risk after discontinuation of risperidone in Alzheimers disease.","volume":"367","author":"Devanand","year":"2012","journal-title":"N Engl J Med"},{"key":"R109-6-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00019442-200508000-00012","article-title":"Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.","volume":"13","author":"Deberdt","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"R110-6-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14656566.2013.764989","article-title":"Aripiprazole in the treatment of Alzheimers disease.","volume":"14","author":"De Deyn","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R111-6-20210129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/gps.1949","article-title":"Improvement in behavioural symptoms in patients with moderate to severe Alzheimers disease by memantine: a pooled data analysis.","volume":"23","author":"Gauthier","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"R112-6-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.v69n0302","article-title":"Memantine for agitationaggression and psychosis in moderately severe to severe Alzheimers disease: a pooled analysis of 3 studies.","volume":"69","author":"Wilcock","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R113-6-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1755-5949.2011.00247.x","article-title":"Hallucinations in neurodegenerative diseases.","volume":"18","author":"Burghaus","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"R114-6-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11940-013-0281-2","article-title":"Treatment of psychosis and dementia in Parkinsons disease.","volume":"16","author":"Goldman","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"R115-6-20210129","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"R116-6-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000101512","article-title":"Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.","volume":"23","author":"Edwards","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R117-6-20210129","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1176\/appi.ajp.2007.07040715","article-title":"Presentation and management of psychosis in Parkinsons disease and dementia with Lewy bodies.","volume":"164","author":"Weintraub","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R119-6-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinsons disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol"},{"key":"R120-6-20210129","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00702-013-0994-0","article-title":"The practical management of cognitive impairment and psychosis in the older Parkinsons disease patient.","volume":"120","author":"Hindle","year":"2013","journal-title":"J Neural Transm"},{"key":"R121-6-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1755-5949.2010.00166.x","article-title":"Effects of cholinesterase inhibitors in Parkinsons disease dementia: a review of clinical data.","volume":"17","author":"van Laar","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"R122-6-20210129","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/npp.2009.176","article-title":"Pimavanserin, a serotonin(2a) receptor inverse agonist, for the treatment of Parkinsons disease psychosis.","volume":"35","author":"Meltzer","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"R123-6-20210129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinsons disease psychosis: a randomised, placebo-controlled phase 3 trial.","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet"},{"key":"R125-6-20210129","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/JGP.0b013e3180cc1ff5","article-title":"A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.","volume":"15","author":"Pollock","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"R126-6-20210129","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1017\/S1041610211000743","article-title":"Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimers disease: a randomized double-blind pilot study.","volume":"23","author":"Barak","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"R127-6-20210129","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CITAD randomized clinical trial.","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"R128-6-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WAD.0b013e3181e6a4d7","article-title":"Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.","volume":"24","author":"Culo","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R129-6-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00124509-200306000-00003","article-title":"Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia.","volume":"19","author":"Suzuki","year":"2003","journal-title":"J ECT"},{"key":"R130-6-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00124509-200406000-00005","article-title":"One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia.","volume":"20","author":"Suzuki","year":"2004","journal-title":"J ECT"},{"key":"R131-6-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1440-1819.2005.01402.x","article-title":"Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.","volume":"59","author":"Suzuki","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"R132-6-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.31887\/DCNS.2008.10.1\/tcbaghai","article-title":"Electroconvulsive therapy and its different indications.","volume":"10","author":"Baghai","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"R133-6-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.9758\/cpn.2013.11.2.53","article-title":"Use of repetitive transcranial magnetic stimulation for treatment in psychiatry.","volume":"11","author":"Aleman","year":"2013","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R134-6-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/070674371105600103","article-title":"What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist.","volume":"56","author":"Sienaert","year":"2011","journal-title":"Can J Psychiatry"},{"key":"R135-6-20210129","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.2174\/138161212803523644","article-title":"The role of transcranial magnetic stimulation in treatment-resistant depression: a review.","volume":"18","author":"Lee","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R136-6-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/YCT.0b013e3181c18a3d","article-title":"Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.","volume":"26","author":"Ueda","year":"2010","journal-title":"J ECT"},{"key":"R137-6-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200326090-00004","article-title":"Treatment of psychosis in Parkinsons disease: safety considerations.","volume":"26","author":"Fernandez","year":"2003","journal-title":"Drug Saf"},{"key":"R138-6-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3171\/jns.2007.106.4.621","article-title":"Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.","volume":"106","author":"Kenney","year":"2007","journal-title":"J Neurosurg"},{"key":"R139-6-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2377-7-7","article-title":"Subthalamic nucleus deep brain stimulation in elderly patientsanalysis of outcome and complications.","volume":"7","author":"Vesper","year":"2007","journal-title":"BMC Neurol"},{"key":"R140-6-20210129","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/mds.10518","article-title":"Two-year follow-up of subthalamic deep brain stimulation in Parkinsons disease.","volume":"18","author":"Herzog","year":"2003","journal-title":"Mov Disord"},{"key":"R141-6-20210129","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11910-003-0007-z","article-title":"Behavioral changes associated with deep brain stimulation surgery for Parkinsons disease.","volume":"3","author":"Anderson","year":"2003","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R142-6-20210129","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1440-1819.2007.01709.x","article-title":"Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic feature.","volume":"61","author":"Katagai","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"R143-6-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1192\/bjp.bp.110.090373","article-title":"Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study.","volume":"199","author":"Taylor","year":"2011","journal-title":"Br J Psychiatry"},{"key":"R144-6-20210129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.psc.2005.08.001","article-title":"Evidence-based review of pharmacologic and nonpharmacologic treatments for older adults with schizophrenia.","volume":"28","author":"Van Citters","year":"2005","journal-title":"Psychiatr Clin North Am"},{"key":"R145-6-20210129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2007.12.468","article-title":"Adjunctive psychosocial therapies for the treatment of schizophrenia.","volume":"100","author":"Patterson","year":"2008","journal-title":"Schizophr Res"},{"key":"R146-6-20210129","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2147\/NDT.S49263","article-title":"Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care.","volume":"9","author":"Chien","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R147-6-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1521\/psyc.2009.72.4.307","article-title":"Evidence-based psychosocial practices and recovery from schizophrenia.","volume":"72","author":"Shean","year":"2009","journal-title":"Psychiatry"},{"key":"R149-6-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2005.02.018","article-title":"The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis.","volume":"77","author":"Zimmermann","year":"2005","journal-title":"Schizophr Res"},{"key":"R150-6-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.312.7027.345","article-title":"Compliance therapy in psychotic patients: randomised controlled trial.","volume":"312","author":"Kemp","year":"1996","journal-title":"BMJ"},{"key":"R151-6-20210129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1192\/bjp.172.5.413","article-title":"Randomised controlled trial of compliance therapy. 18-month follow-up.","volume":"172","author":"Kemp","year":"1998","journal-title":"Br J Psychiatry"},{"key":"R152-6-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-clinpsy-050212-185620","article-title":"Psychosocial treatments for schizophrenia.","volume":"9","author":"Mueser","year":"2013","journal-title":"Annu Rev Clin Psychol"},{"key":"R153-6-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archinternmed.2009.489","article-title":"Effects of exercise programs to prevent decline in health-related quality of life in highly deconditioned institutionalized elderly persons: a randomized controlled trial.","volume":"170","author":"Dechamps","year":"2010","journal-title":"Arch Intern Med"},{"key":"R154-6-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/jgs.12682","article-title":"Effect of music therapy versus recreational activities on neuropsychiatric symptoms in elderly adults with dementia: an exploratory randomized controlled trial.","volume":"62","author":"Vink","year":"2014","journal-title":"J Am Geriatr Soc"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HRP.0000000000000068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T12:25:58Z","timestamp":1691929558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201509000-00006"}},"subtitle":["A Review and Update"],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":145,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/hrp.0000000000000068","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}